0001209191-13-038501.txt : 20130731 0001209191-13-038501.hdr.sgml : 20130731 20130731163049 ACCESSION NUMBER: 0001209191-13-038501 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130729 FILED AS OF DATE: 20130731 DATE AS OF CHANGE: 20130731 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6173416100 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Riley Wayne Joseph CENTRAL INDEX KEY: 0001432895 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 13999395 MAIL ADDRESS: STREET 1: 1005 DR D.B. TODD BLVD CITY: NASHVILLE STATE: TN ZIP: 37208 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-07-29 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001432895 Riley Wayne Joseph C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2013-07-29 4 M 0 10000 33.89 A 10000 D Common Stock 2013-07-29 4 S 0 9700 80.08 D 300 D Common Stock 2013-07-29 4 S 0 100 81.18 D 200 D Stock Option 33.89 2013-07-29 4 M 0 10000 0.00 D 2020-07-08 Common Stock 10000 20000 D Transaction made pursuant to Dr. Riley's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $80.08 (range $80.00 to $80.92). Dr. Riley undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. The option vests in 16 quarterly installments from 07/09/2010. Omar White, Attorney-In-Fact 2013-07-31